ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

Keytruda Granted Approval In Metastatic Melanoma

September 26, 2014

In Brief: DeVita wins $150,000 Pezcoller Prize; BreastPac To “Storm” Capitol On Bastille Day For More $$

July 8, 1988

NCI Planning Phase III Study Of Avastin For Metastatic Colorectal Cancer

June 27, 2003

ASCO To Begin Large Study On Quality Of Cancer Care.

January 28, 2000

Panel to Hear Innovation Reports

August 26, 1988